Total planned funding: $254,461,163
Allocations
Countries/Regions
Eswatini | $254,461,163 |
Organizational Types
Private Contractor | $68,987,037 |
NGO | $46,552,606 |
University | $44,820,708 |
Unknown | $38,879,306 |
Own Agency | $32,424,571 |
FBO | $10,806,488 |
Host Country Government Agency | $8,142,398 |
Other USG Agency | $2,298,449 |
Multi-lateral Agency | $1,380,000 |
Implementing Agency | $169,600 |
Program Areas
Care | $68,246,534 |
Treatment | $68,069,514 |
Prevention | $51,786,984 |
Governance and Systems | $24,274,409 |
Testing | $21,160,150 |
Management and Operations | $20,923,572 |
Budget Codes
HTXS: Treatment: Adult Treatment | $58,820,090 |
HBHC: Care: Adult Care and Support | $28,553,753 |
HKID: Care: Orphans and Vulnerable Children | $25,750,546 |
HVCT: Testing: HIV Testing and Counseling | $21,160,150 |
HVMS: Management and Operations | $20,923,572 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,438,817 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,321,144 |
OHSS: Health Systems Strengthening | $10,617,758 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,904,697 |
HVTB: Care: TB/HIV | $9,273,367 |
HVSI: Strategic Information | $9,236,124 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,997,326 |
PDTX: Treatment: Pediatric Treatment | $4,922,101 |
PDCS: Care: Pediatric Care and Support | $4,668,868 |
HLAB: Laboratory Infrastructure | $4,420,527 |
HTXD: Treatment: ARV Drugs | $4,327,323 |
HMBL: Biomedical Prevention: Blood Safety | $1,125,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$35,657,332
Countries/Regions
Pact, Inc.:
$32,873,742
Countries/Regions
Not Available:
$20,419,440
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions